United States · Seed startup

Who invested in Eragon

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AI

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$12Mraised across 1 round since 2026, from 1 source

Latest round
Seed, $12MMar 2026
Investors
4
See who backed them

The rounds

  1. Mar 2026

Founders and team

From Eragon's own website: 4 founders, 1 on the team.

Nico LaquaCEO & Founder
Victor Cardenas CodrianskyCEO & Co-Founder
MichAEl KimCo-Founder
Sid RajaramCo-Founder
  • Nicky HeLabs Head of Operations, Staff & Finance

Everyone who backed them

Alumni VenturesVC firm1round
Soma CapitalVC firm1round
K5 GlobalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Eragon as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Mento VCVC firmPer its own site
Roo CapitalVC firmPer its own site
Beat VenturesVC firmPer its own site

Quick answers about Eragon

Who invested in Eragon?

Eragon's investors include Alumni Ventures, Soma Capital, K5 Global and Long Journey Ventures.

How much has Eragon raised?

Eragon has raised $12M across 1 round since 2026.

When did Eragon last raise?

Eragon's most recent round was a Seed of $12M in Mar 2026.

What was Eragon's biggest round?

Its most recent round, $12M in Mar 2026, is also its largest on record.

Who backed Eragon first?

Eragon's first round on record, in Mar 2026, was backed by Alumni Ventures, Soma Capital and K5 Global and 1 others.

What stage is Eragon at?

Eragon's latest named round is a Seed, in Mar 2026.

Where is Eragon based?

Eragon is based in the United States.

Companies like Eragon

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.